Breast Cancer Cure- New TM trail
The cure is near
According to Cancer Statistics Working Group, breast cancer rates in 2009 stood at 211,731 women being diagnosed with breast cancer (USA only)
An independent trial funded by many public donations has been well underway and is due to be completed in June 2013 and is set to change the face of breast cancer for the future. TM (tetra-thio-molybdate) is the name of the drug that is being trialed by Weill Medical College of Cornell University.
Breast Cancer Survivor Trials TM
After listening to Harvard educated Dr Katherine Albrecht on Infowars.com last night, I found out that she herself has had breast cancer, and is now trialing these drugs. The most important claim, is that these drugs have no nasty side affects.
If you don't know of Katherine; she has long been a dedicated campaigner for consumer privacy and is a sought after speaker, as well as an author of 6 books including '"Spychips: How major corporations and government plan to track your every move...'
Next week the trial details are to be published in the New York times,
"These study findings are very promising and potentially a very exciting advance in our efforts to help women who are at the highest risk of recurrence," - Dr. Linda Vahdat, director of the Breast Cancer Research Program, chief of the Solid Tumor Service and professor of medicine at Weill Cornell Medical College.
Breast Cancer Statistics
- US Cancer Statistics: An Interactive Atlas
An interactive map of cancer statisitcs
Katherine's Radio Show
- About the show
Katherine Albrecht - Syndicated Talk Radio Host
Clinical trial of TM and similar
Scientists at Cornwell Medical Universtiy are now trialing TM, (which is not currently approved by the FDA) to try to prevent the spread of tumorous cells reproducing new blood vessels. Blood vessels can be formed by tumors, which can accelerate cancer cells throughout the body, this process is called 'angiogenesis'. The study will be particularly interested in eradicating copper stores found in the body, which will be achieved by patients taking the TM drug.
The properties of TM
- AMMONIUM TETRATHIOMOLYBDATE CAS#: 15060-55-6
ChemicalBook provide Chemical industry users with AMMONIUM TETRATHIOMOLYBDATE(15060-55-6) Boiling point Melting point,AMMONIUM TETRATHIOMOLYBDATE(15060-55-6) Density MSDS Formula Use,If You also need to AMMONIUM TETRATHIOMOLYBDATE(15060-55-6) Other i
Who is eligible ?
Woman who are at
- High-Risk Stage II Breast Cancer
- Stage III Breast Cancer
- Stage IV Breast or cancer in remission
details found at http://www.cornellmedicine.org
The role of copper
There is no denying that copper is one of, if not the most important mineral founds in our body and we need it to function at a healthy level- so why then is the reduction of copper linked to cancer treatments?
Copper (CU) serum has been associated with cancer, due to being found at high levels in animals and humans with cancerous cells. According to www.oralchelation.com the elevated levels of copper in the body could be the body's response to the cancer. Some experiments have even found that copper can cause cancerous cells to transform into normal cells. For these reasons, scientists are excited by the new possibilities of copper in the application to cancer studies